Fig. 3.
Kaplan-Meier analysis comparing disease-free survival of patients with PML-RARα NQ exceeding 10−5 versus patients with NQ below 10−5 after completion of protocol INT0129 consolidation therapy.
Open circles indicate censored cases. Median follow-up was 69 months measured from the achievement of complete remission.